Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Foletta Mark G
Relationship:   EVP & Chief Financial ...
City:   San Diego
State:   CA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   110,179    

Indirect Shares

   62,398      
Direct Value   $1,139,767    

Indirect Value

   $7,947,633      
Total Shares   172,577      
Total Value   $9,087,400      


DexCom Inc $378,671 Regulus Therapeutics Inc. $165,458 AMN Healthcare Services Inc $576,685 Forte Biosciences Inc $18,953 DexCom Inc $378,671 Regulus Therapeutics Inc. $165,458 AMN Healthcare Services Inc $576,685 Forte Biosciences Inc $18,953
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    1    

     Stock price went up :
    1   
    1    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   1.0   
   1.0   
     Percentage Gain/Loss :
   0.7%
 13.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Amylin Pharmaceuticals Inc AMLN SVP, Chief Financial O... 2012-08-08 0 2012-08-08 0    Premium*  
            DexCom Inc DXCM Director 2024-05-22 2,973 2024-05-22 62,398    Premium*  
            Regulus Therapeutics Inc. RGLS Director 2017-12-04 81,910 2015-08-13 0    Premium*  
            AMN Healthcare Services Inc AHS Director 2024-04-19 10,254 2016-04-20 0    Premium*  
            Forte Biosciences Inc FBRX EVP & Chief Financial ... 2019-05-28 15,042 2017-04-19 0    Premium*  
* Premium Members only  

Records found :    144         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 4 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
AMLN Amylin Pharmaceuticals In... Senior VP, Finance & CFO   •       –      –    2006-10-31 4 OE $11.13 $27,813 D/D 2,500 25,094 0 -
AMLN Amylin Pharmaceuticals In... Senior VP, Finance & CFO   •       –      –    2006-11-30 4 OE $11.13 $28,832 D/D 2,500 23,830 0 -
AMLN Amylin Pharmaceuticals In... Senior VP, Finance & CFO   •       –      –    2006-11-30 4 AS $40.76 $101,900 D/D (2,500) 22,594 0 -
AMLN Amylin Pharmaceuticals In... Senior VP, Finance & CFO   •       –      –    2006-12-29 4 AS $35.89 $89,725 D/D (2,500) 22,594 0 -
AMLN Amylin Pharmaceuticals In... Senior VP, Finance & CFO   •       –      –    2006-12-29 4 OE $11.95 $29,875 D/D 2,500 25,094 0 -
AMLN Amylin Pharmaceuticals In... Senior VP, Finance & CFO   •       –      –    2007-01-31 4 OE $11.95 $29,875 D/D 2,500 25,094 0 -
AMLN Amylin Pharmaceuticals In... Senior VP, Finance & CFO   •       –      –    2007-01-31 4 AS $39.00 $97,500 D/D (2,500) 22,594 0 -
AMLN Amylin Pharmaceuticals In... Senior VP, Finance & CFO   •       –      –    2007-01-31 4 A $36.07 $15,005 D/D 416 23,010 0 -
AMLN Amylin Pharmaceuticals In... Senior VP, Finance & CFO   •       –      –    2007-02-28 4 OE $11.95 $33,107 D/D 2,500 25,728 0 -
AMLN Amylin Pharmaceuticals In... Senior VP, Finance & CFO   •       –      –    2007-02-28 4 A $33.07 $7,673 D/D 232 23,242 0 -
AMLN Amylin Pharmaceuticals In... Senior VP, Finance & CFO   •       –      –    2007-02-28 4 AS $38.82 $97,050 D/D (2,500) 23,242 0 -
AMLN Amylin Pharmaceuticals In... Senior VP, Finance & CFO   •       –      –    2007-03-30 4 AS $37.61 $94,025 D/D (2,500) 23,242 0 -
AMLN Amylin Pharmaceuticals In... Senior VP, Finance & CFO   •       –      –    2007-03-30 4 OE $13.25 $33,125 D/D 2,500 25,742 0 -
AMLN Amylin Pharmaceuticals In... Senior VP, Finance & CFO   •       –      –    2007-04-30 4 AS $42.32 $105,800 D/D (2,500) 23,242 0 -
AMLN Amylin Pharmaceuticals In... Senior VP, Finance & CFO   •       –      –    2007-04-30 4 OE $13.25 $33,125 D/D 2,500 25,742 0 -
AMLN Amylin Pharmaceuticals In... Senior VP, Finance & CFO   •       –      –    2007-05-31 4 AS $45.79 $297,663 D/D (6,500) 23,242 0 -
AMLN Amylin Pharmaceuticals In... Senior VP, Finance & CFO   •       –      –    2007-05-31 4 OE $13.25 $86,125 D/D 6,500 29,742 0 -
AMLN Amylin Pharmaceuticals In... Senior VP, Finance & CFO   •       –      –    2007-06-29 4 OE $13.25 $33,125 D/D 2,500 25,742 0 -
AMLN Amylin Pharmaceuticals In... Senior VP, Finance & CFO   •       –      –    2007-06-29 4 AS $41.38 $103,455 D/D (2,500) 23,242 0 -
AMLN Amylin Pharmaceuticals In... Senior VP, Finance & CFO   •       –      –    2007-07-31 4 OE $13.25 $46,375 D/D 3,500 26,742 0 -
AMLN Amylin Pharmaceuticals In... Senior VP, Finance & CFO   •       –      –    2007-07-31 4 AS $47.43 $166,022 D/D (3,500) 23,242 0 -
AMLN Amylin Pharmaceuticals In... Senior VP, Finance & CFO   •       –      –    2007-08-31 4 OE $13.25 $39,750 D/D 3,000 26,242 0 -
AMLN Amylin Pharmaceuticals In... Senior VP, Finance & CFO   •       –      –    2007-08-31 4 AS $48.86 $146,575 D/D (3,000) 23,242 0 -
AMLN Amylin Pharmaceuticals In... Senior VP, Finance & CFO   •       –      –    2007-09-28 4 OE $13.25 $39,750 D/D 3,000 26,242 0 -
AMLN Amylin Pharmaceuticals In... Senior VP, Finance & CFO   •       –      –    2007-09-28 4 AS $49.98 $149,932 D/D (3,000) 23,242 0 -
  144  Records found
  1   2   3   4  5   6      
  Page 4 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us